Contrast-enhanced ultrasound of the pancreas - A method beyond its potential or a new diagnostic standard?

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 2, 2009, Pages 237-242

  Badea, Radu ^a   Seicean, Andrada ^a   Diaconu, Brindusa ^a   Stan Iuga, Roxana ^a   Sparchez, Zeno ^a   Tantau, Marcel ^a   Socaciu, Mihai ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Contrast enhanced ultrasonography; Cystic tumors; Neoplasm; Pancreas; Pancreatitis

Indexed keywords

SONOVUE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ACUTE PANCREATITIS; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PANCREAS DISEASE; PANCREAS PSEUDOTUMOR; PERFORMANCE MEASUREMENT SYSTEM; PROCESS OPTIMIZATION; PSEUDOTUMOR; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; VARICOSIS; PANCREAS; PREDICTION AND FORECASTING;

CONTRAST MEDIA; HUMANS; PANCREAS; PANCREATIC DISEASES; PREDICTIVE VALUE OF TESTS;

EID: 70149090241     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. World Health Organization. The world health report. WHO 2000.
2. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223: 603-613. (Pubitemid 34547572)
3. Foitzik T, Bassi DG, Fernandez del Castillo C, et al.Intravenous contrast medium impairs oxygenation of the pancreas in acute necrotizing pancreatitis in the rat. Arch Surg 1994; 129: 706-711. (Pubitemid 24208712)
4. Hartmann D, Schilling D, Bassler B, et al.ERCP and MRCP in the differentiation of pancreatic tumors. Dig Dis 2004; 22: 18-25. (Pubitemid 39070143)
5. Furukawa T, Naitoh Y, Tsukamoto Y, et al. New technique using intraductal ultrasonography for the diagnosis of diseases of the pancreatobiliary system. J Ultrasound Med 1992; 11: 607-612. (Pubitemid 23047043)
6. Tio TL, Sie LH, Kallimanis G, et al. Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery. Gastrointest Endosc 1996; 44: 706-713. (Pubitemid 26428332)
7. GandolfiL, Torresan F, Solmi L, et al.The role of ultrasound in biliary and pancreatic diseases. Eur J Ultrasound 2003; 16: 141-159. (Pubitemid 36173570)
8. Summa M, Perrone F, Priora F, et al.Integrated clinicalultrasonographic diagnosis in acute appendicitis. J Ultrasound 2007; 10: 175-178. (Pubitemid 350184430)
9. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25: 756-759.
10. Bradley III EL. The necessity for a clinical classification of acute pancreatitis: the Atlanta system. In: Bradley EL III, eds. Acute pancreatitis, diagnosis and therapy. New York: Raven Press, 1994: 53-62.
11. Garg M, Sandhu M, Sood B, et al. Tissue harmonic imaging in the evaluation of acute pancreatitis. Australas Radiol 2004; 48: 117-122. (Pubitemid 39044144)
12. Karlson BM, Ekbom A, Lindgren PG, et al. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology 1999; 213: 107-111. (Pubitemid 29470415)
13. Recaldini C, Carrafiello G, Bertolotti E, et al. Contrast-enhanced ultrasonographic findings in pancreatic tumors. Int J Med Sci 2008; 5: 203-208.
14. Philips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol 2004; 14(Suppl 8): P4 - 10.
15. Cosgrove D, Eckersley R. Contrast-enhanced ultrasound. Basic physics and technology overview. In: Lencioni R (ed). Enhancing the Role of Ultrasound with Contrast Agents, Springer, Berlin, 2006: 3-14.
16. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35: 58-71.
17. Kitano M, Kudo M, Maekawa K, et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004; 53: 854-859. (Pubitemid 38662136)
18. Rickes S, Uhle C, Kahl S, et al. Echo enhanced ultrasound: a new valid initial imaging approach for severe acute pancreatitis. Gut 2006; 55: 74-78. (Pubitemid 41820639)
19. Rickes S, Unkrodt K, Neye H, et al. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol 2002; 37:1313-1320. (Pubitemid 35305770)
20. Rickes S, Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J Gastroenterol Hepatol 2004; 19: 761-766. (Pubitemid 38981397)
21. D'Onofrio M, Zamboni G, Tognolini A, et al. Mass-forming pancreatitis: value of contrast enhanced ultrasonography. World J Gatroenterol 2006; 12: 4181-4184. (Pubitemid 44376898)
22. Van Gulik TM, Reeders JW, Bosma A, et al. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 1997; 46: 417-423. (Pubitemid 27498388)
23. Oshikawa O, Tanaka S, Ioka T, et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol 2002; 178: 1133-1137. (Pubitemid 34411407)
24. D'Onofrio M, Zamboni G, Faccioli N, et al. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 2007; 32: 171-181.
25. Dietrich CF, Braden B, Hocke M, et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 2008; 134: 635-643.
26. Faccioli N, D'Onofrio M, Malago R, et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas 2008; 37: 265-268.
27. Sofuni A, Itoi T, Itokawa F, et al. Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. World J Gastroenterol 2008; 14: 7183-7191.
28. Stefanini P, Carboni M, Patrassi N, et al. Beta-islet cell tumors of the pancreas: results of a study on 1067 cases. Surgery 1974; 75: 597-609.
29. D'Onofrio M, Mansueto G, Vasori S, et al. Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 2003; 22: 413-417, (Pubitemid 36686825)
30. Rickes S, Mönkemüller K, Malfertheiner P. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors . JOP 2006; 7: 584-592.
31. D'Onofrio M, Mansueto G, Falconi M, et al Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 2004; 29: 246-258.
32. Rickes S, Unkrodt K, Ocran K, et al. Differentiation of neuroendocrine tumours from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy. Pancreas 2003; 26: 76-81.
33. Flath B, Rickes S, Schweigert M, et al. Differentiation of pancreatic metastasis of a renal cell carcinoma from primary pancreatic carcinoma by echo-enhanced power Dopple sonography. Pancreatology 2003; 3: 349-351. (Pubitemid 36928762)
34. Megibow AJ. Secondary pancreatic tumors: imaging. In: Procacci C, Megibow AJ (eds) Imaging of the pancreas. Cystic and rare tumors. Springer-Verlag: Berlin, 2003: 277-288.
35. Sahani DV, Kadavigere R, Saokar A, et alCystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005; 25: 1471-1484. (Pubitemid 41695317)
36. D'Onofrio M, Megibow AJ, Faccioli N, et al. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. Am J Roentgenol 2007; 189: 1435-1442. (Pubitemid 350174806)